Clinical Trial Update: Creatine for Treatment of Depression Associated With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating creatine for depression in patients with type 2 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: University of Utah | Conditions: Major Depressive Disorder | Phase 4 | Status: WITHDRAWN